KMT2A and neoplasm: Our previous study, examining global gene expression profiles at day 10 after tumor cell injection, suggests that MLL-LNs when compared to AT1-LNs is characterized by decreased quantity, differentiation, and activation of immune cells, and by signs of immune evasion [11].